日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study.

达沙替尼、紫杉醇和卡铂治疗晚期或复发性子宫内膜癌女性：一项初步临床和转化研究

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2021.01.022
Coleman Robert L, Hu Wei, Soliman Pamela, Nick Alpa, Ramirez Pedro T, Westin Shannon N, Garcia Michael E, Zhu Zhifei, Palancia Julieta, Fellman Bryan M, Yuan Ying, Ram Prahlad, Bischoff Farideh, Schmeler Kathleen, Bodurka Diane, Meyer Larissa A, Sood Anil K
肿瘤
发表日期：2021
文献求助 收藏

A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium

一项针对FIGO I-IIIA期（1988年）子宫内膜乳头状浆液性癌的放化疗后辅助化疗的前瞻性II期研究

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2013.01.025
Jhingran, Anuja; Ramondetta, Lois M; Bodurka, Diane C; Slomovitz, Brian M; Brown, Jubilee; Levy, Lawrence B; Garcia, Michael E; Eifel, Patricia J; Lu, Karen H; Burke, Thomas W
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏

Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

多西他赛联合阿柏西普治疗复发性卵巢癌、原发性腹膜癌或输卵管癌患者的I/II期研究

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(11)70244-3
Coleman, Robert L; Duska, Linda R; Ramirez, Pedro T; Heymach, John V; Kamat, Aparna A; Modesitt, Susan C; Schmeler, Kathleen M; Iyer, Revathy B; Garcia, Michael E; Miller, Debbie L; Jackson, Edward F; Ng, Chaan S; Kundra, Vikas; Jaffe, Robert; Sood, Anil K
肿瘤
肿瘤免疫
卵巢癌
发表日期：2011
文献求助 收藏

HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.

适用于高通量筛选的患者来源细胞检测方法，用于鉴定 1 型强直性肌营养不良症中异常剪接的小分子调节剂

期刊:
影响因子:
doi:10.2174/1875397301004010009
O'Leary Debra A, Vargas Leonardo, Sharif Orzala, Garcia Michael E, Sigal Yury J, Chow Siu-Kei, Schmedt Christian, Caldwell Jeremy S, Brinker Achim, Engels Ingo H
细胞生物学
发表日期：2010
文献求助 收藏

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma

一项针对伴有卵巢癌或原发性腹膜癌的腹膜癌（残留病灶<1 cm）患者的II期临床研究，评估腹腔内注射重组人白细胞介素-12 (rhIL-12) 的疗效。

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-5-66
Lenzi, Renato; Edwards, Robert; June, Carl; Seiden, Michael V; Garcia, Michael E; Rosenblum, Michael; Freedman, Ralph S
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2007
文献求助 收藏

Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

在接受卡铂治疗的复发性卵巢癌患者中，通过化疗前和化疗后循环给予细胞因子、GM-CSF 和 IFNγ

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-4-16
Apte, Sachin M; Vadhan-Raj, Saroj; Cohen, Lorenzo; Bassett, Roland L; Gordon, Ilyssa O; Levenback, Charles F; Ramirez, Pedro T; Gallardo, Stacie T; Patenia, Rebecca S; Garcia, Michael E; Iyer, Revathy B; Freedman, Ralph S
肿瘤
肿瘤免疫
IFNγ
卵巢癌
M-CSF
细胞生物学
GM-CSF
免疫/内分泌
发表日期：2006
文献求助 收藏